• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lack of significant association between dyslipidemia and COVID-19 mortality.

作者信息

Yang Haiyan, Hou Hongjie, Liang Xuan, Xu Jie, Wang Yadong

机构信息

Department of Epidemiology, School of Public Health, Zhengzhou University, No. 100 of Science Avenue, Zhengzhou 450001, China.

Department of Epidemiology, School of Public Health, Zhengzhou University, No. 100 of Science Avenue, Zhengzhou 450001, China.

出版信息

J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.03.001. Epub 2021 Mar 5.

DOI:10.1016/j.jinf.2021.03.001
PMID:33684401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7934672/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f5/7934672/8efb6d27f82c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f5/7934672/8efb6d27f82c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f5/7934672/8efb6d27f82c/gr1_lrg.jpg

相似文献

1
Lack of significant association between dyslipidemia and COVID-19 mortality.血脂异常与新冠病毒疾病死亡率之间缺乏显著关联。
J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.03.001. Epub 2021 Mar 5.
2
Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection.血脂异常与2019冠状病毒病（COVID-19）重症感染相关。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1463-1465. doi: 10.1016/j.dsx.2020.07.054. Epub 2020 Aug 1.
3
ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study.ACE 基因变异使高血压、血脂异常或糖尿病患者患严重 COVID-19 的风险增加：一项西班牙试点研究。
Front Endocrinol (Lausanne). 2021 Aug 19;12:688071. doi: 10.3389/fendo.2021.688071. eCollection 2021.
4
Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis.血脂异常与 2019 年冠状病毒病（COVID-19）严重程度和死亡率的关系：一项荟萃分析。
Virol J. 2021 Jul 27;18(1):157. doi: 10.1186/s12985-021-01604-1.
5
Dyslipidemia in breast cancer patients increases the risk of SAR-CoV-2 infection.乳腺癌患者的血脂异常会增加 SARS-CoV-2 感染的风险。
Infect Genet Evol. 2021 Aug;92:104883. doi: 10.1016/j.meegid.2021.104883. Epub 2021 Apr 24.
6
SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.SARS-CoV-2 感染和 COVID-19 死亡率与 ACE1 I/D 基因型密切相关。
Gene. 2020 Oct 20;758:144944. doi: 10.1016/j.gene.2020.144944. Epub 2020 Jul 3.
7
Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study.血管紧张素转换酶基因型与 COVID-19 死亡率：一项生态学研究。
J Infect. 2020 Dec;81(6):961-965. doi: 10.1016/j.jinf.2020.11.012. Epub 2020 Nov 14.
8
Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.组胺 2 受体拮抗剂和质子泵抑制剂与 SARS-CoV-2 感染风险降低相关，无论是否存在糖尿病、高血压和血脂异常等合并症：一项倾向评分匹配的全国队列研究。
J Korean Med Sci. 2023 Apr 3;38(13):e99. doi: 10.3346/jkms.2023.38.e99.
9
SARS-CoV-2 infection and ACE2 inhibition.严重急性呼吸综合征冠状病毒2感染与血管紧张素转换酶2抑制
J Hypertens. 2021 Aug 1;39(8):1555-1558. doi: 10.1097/HJH.0000000000002859.
10
Commentary for "Endocrine significance of SARS-CoV-2's Reliance on ACE2".《新型冠状病毒依赖血管紧张素转换酶2的内分泌学意义》述评
Endocrinology. 2021 Apr 1;162(4). doi: 10.1210/endocr/bqaa222.

引用本文的文献

1
Characteristics, Mortality, and Clinical Outcomes of Hospitalized Patients with COVID-19 and Diabetes: A Reference Single-Center Cohort Study from Poland.COVID-19合并糖尿病住院患者的特征、死亡率及临床结局：一项来自波兰的单中心队列参考研究
Int J Endocrinol. 2023 Feb 16;2023:8700302. doi: 10.1155/2023/8700302. eCollection 2023.
2
Low-density lipoprotein particles carrying proinflammatory proteins with altered aggregation pattern detected in COVID-19 patients 3 months after hospitalization.在COVID-19患者住院3个月后检测到携带促炎蛋白且聚集模式改变的低密度脂蛋白颗粒。
J Infect. 2023 May;86(5):489-492. doi: 10.1016/j.jinf.2023.02.024. Epub 2023 Feb 21.
3

本文引用的文献

1
Clinical Characterization of Patients With COVID-19 in Primary Care in Catalonia: Retrospective Observational Study.在加泰罗尼亚的初级保健中 COVID-19 患者的临床特征：回顾性观察研究。
JMIR Public Health Surveill. 2021 Feb 8;7(2):e25452. doi: 10.2196/25452.
2
Autoimmune diseases are independently associated with COVID-19 severity: Evidence based on adjusted effect estimates.自身免疫性疾病与新冠病毒疾病严重程度独立相关：基于校正效应估计的证据
J Infect. 2021 Apr;82(4):e23-e26. doi: 10.1016/j.jinf.2020.12.025. Epub 2020 Dec 28.
3
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
Pulmonary recovery from COVID-19 in patients with metabolic diseases: a longitudinal prospective cohort study.
代谢性疾病患者 COVID-19 肺部康复：一项纵向前瞻性队列研究。
Sci Rep. 2023 Feb 14;13(1):2599. doi: 10.1038/s41598-023-29654-1.
4
Assessment of Risk Factors Associated with COVID-19 Illness Outcomes in a Tertiary Hospital in Saudi Arabia.沙特阿拉伯一家三级医院中与COVID-19疾病结局相关的风险因素评估。
Int J Gen Med. 2022 Jun 27;15:5823-5833. doi: 10.2147/IJGM.S357676. eCollection 2022.
5
Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case-control study.伊朗克尔曼沙阿医疗中心收治的 COVID-19 患者血脂谱变化：病例对照研究。
J Int Med Res. 2022 Feb;50(2):3000605221078699. doi: 10.1177/03000605221078699.
6
Mendelian randomization reveals potential causal candidates for COVID-19 in 123 blood metabolites.孟德尔随机化揭示了123种血液代谢物中新冠病毒潜在的因果候选因素。
J Infect. 2022 Feb;84(2):248-288. doi: 10.1016/j.jinf.2021.09.002. Epub 2021 Sep 14.
与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
4
Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎患者的性别、年龄及合并症与死亡率的关联：一项系统综述和荟萃分析
Intervirology. 2020 Dec 9:1-12. doi: 10.1159/000512592.
5
Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study.血管紧张素转换酶基因型与 COVID-19 死亡率：一项生态学研究。
J Infect. 2020 Dec;81(6):961-965. doi: 10.1016/j.jinf.2020.11.012. Epub 2020 Nov 14.
6
Machine learning prediction for mortality of patients diagnosed with COVID-19: a nationwide Korean cohort study.基于全国韩国队列研究的 COVID-19 患者死亡率的机器学习预测。
Sci Rep. 2020 Oct 30;10(1):18716. doi: 10.1038/s41598-020-75767-2.
7
Characteristics and Prognosis of COVID-19 in Patients with COPD.慢性阻塞性肺疾病患者感染新型冠状病毒肺炎的特征及预后
J Clin Med. 2020 Oct 12;9(10):3259. doi: 10.3390/jcm9103259.
8
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
9
The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates.高血压与新冠病毒肺炎患者严重程度及死亡率的关联：基于校正效应估计值的证据
J Infect. 2020 Sep;81(3):e44-e47. doi: 10.1016/j.jinf.2020.06.060. Epub 2020 Jun 25.